Skip to main content

Diadema Partners Lp

Source: SEC Form 13F · as of Mar 2026

Diadema Partners Lp holds 48 biotech & pharma companies tracked by BioSniper, totaling $150.6M in value as of Mar 2026 (SEC Form 13F).

Companies held

48

Total value held

$150.6M

BioSniper AIPage evidence connected

Prepared research question

What matters most for Viking Therapeutics, Inc. (VKTX)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
VKTXViking Therapeutics, Inc.525,181$17.1M
COGTCogent Biosciences, Inc.322,764$12.4M
JAZZJazz Pharmaceuticals plc54,755$10.4M
TERNTerns Pharmaceuticals, Inc.181,752$9.6M
BMRNBIOMARIN PHARMACEUTICAL INC148,229$8.4M
ABVXAbivax SA75,944$8.2M
RVMDREVOLUTION MEDICINES, INC.80,872$7.9M
KODKodiak Sciences Inc.192,962$7.4M
INCYIncyte Corp.78,029$7.3M
TGTXTG THERAPEUTICS, INC.206,928$6.9M
BBIOBridgeBio Pharma, Inc.85,311$6.3M
IMCRImmunocore Holdings plc193,189$5.8M
RCUSArcus Biosciences, Inc.238,142$5.1M
CRBPCorbus Pharmaceuticals Holdings, Inc.439,957$4.1M
ZYMEZymeworks Inc.142,132$3.6M
GPCRStructure Therapeutics Inc.72,234$3.5M
TENXTENAX THERAPEUTICS, INC.179,738$2.9M
CAPRCAPRICOR THERAPEUTICS, INC.78,851$2.4M
BCYCBICYCLE THERAPEUTICS PLC476,424$2.2M
CLYMClimb Bio, Inc.286,126$2.0M
IVAInventiva S.A.352,399$1.9M
VYGRVoyager Therapeutics, Inc.423,642$1.6M
PCVXVaxcyte, Inc.25,071$1.5M
RLMDRELMADA THERAPEUTICS, INC.200,842$1.4M
BIOABioAge Labs, Inc.60,000$1.0M
INOINOVIO PHARMACEUTICALS, INC.562,665$979K
AYTUAYTU BIOPHARMA, INC353,077$964K
DNTHDianthus Therapeutics, Inc. /DE/10,000$839K
PHVSPharvaris N.V.29,321$828K
XERSXeris Biopharma Holdings, Inc.132,746$770K
LRMRLarimar Therapeutics, Inc.166,637$750K
ANNXAnnexon, Inc.132,916$736K
PTHSPelthos Therapeutics Inc.24,773$520K
QUREuniQure N.V.31,200$510K
MAZEMaze Therapeutics, Inc.15,000$448K
LPCNLipocine Inc.50,000$400K
GHRSGH Research PLC26,836$377K
OCGNOcugen, Inc.200,000$362K
PRQRProQR Therapeutics N.V.180,083$292K
PGENPRECIGEN, INC.55,293$214K
UPBUpstream Bio, Inc.21,609$194K
CMPSCOMPASS Pathways plc31,885$176K
TLPHTALPHERA, INC.153,563$115K
RCKTRocket Pharmaceuticals Inc.30,579$109K
VTGNVistagen Therapeutics, Inc.105,428$60K
RNAAtrium Therapeutics Inc.2,512$34K
CUECue Biopharma, Inc.131,997$30K
ELVNEnliven Therapeutics, Inc.245$10K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.